Taste changes may relate to delayed gastric emptying, GLP-1 receptor activity in taste buds and brain reward centres, or accompanying gastrointestinal symptoms like nausea
These trials will be critical in determining whether the promising phase 2 signals translate into robust, long-term clinical outcomes and an acceptable safety profile sufficient for regulatory submission to bodies such as the MHRA and EMA
Better Balance, Better You isn't a tagline, it's the clinical philosophy that ties together chronic weight management, hormone optimization, and overall wellness
Its the same process that occurs when a bodybuilder stops lifting the muscle simply shrinks to match the reduced workload
Serious side effects remain rare but require immediate medical attention
In clinical trials, semaglutide has demonstrated robust reductions in hemoglobin A1c (HbA1c), with mean decreases ranging from 1.0% to 1.8% depending on the dose and patient population